Changing Landscape of Targeted and Immunotherapies for Genitourinary Cancers – Enduring Webcast

Description

Program Description

---

This webcast is intended to improve care of patients with genitourinary cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Intended Audience

---

This webcast is designed to meet the educational needs of hematologists/oncologists, physician assistants, nurse practitioners, registered nurses, pharmacists and fellows in training involved in the diagnosis and treatment of patients with genitourinary cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma).

Commercial Supporter

---

Supported by Eisai, Inc and Bristol-Myers Squibb